Company Profiles

driven by the PitchBook Platform

Dragonfly Sciences

Description

Developer of biosimilar products designed to offer complex monoclonal antibodies and soluble receptors. The company's biosimilar products integrates advanced biology tools and precision bioanalytics necessary to develop products to meet the most rigorous regulatory standards for safety and efficacy, providing the biotechnology industry with drugs for treating serious and life threatening disorders ranging from cancer to autoimmune diseases.

2005

Founded

OOB

Status

11-50

Employees

Out of Business

Latest Deal Type

$7.97M

Total Amount Raised

Description

Developer of biosimilar products designed to offer complex monoclonal antibodies and soluble receptors. The company's biosimilar products integrates advanced biology tools and precision bioanalytics necessary to develop products to meet the most rigorous regulatory standards for safety and efficacy, providing the biotechnology industry with drugs for treating serious and life threatening disorders ranging from cancer to autoimmune diseases.

Website:

www.dragonflysciences.com

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Other Healthcare Technology Systems

Other Industries

Biotechnology

Primary Office

888 Worcester Street Suite 90 Wellesley, MA 02482United States +1 (781) 416-2730
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Dragonfly Sciences's full profile, request a free trial.

Dragonfly Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Dragonfly Sciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Dragonfly Sciences Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Frank Lee Ph.DFounder, Board Member & Chief Executive Officer
Elizabeth Moyer Ph.DHead, Nonclinical Development
Michael Gramer Ph.DHead of Process Development and Manufacturing
John Abrams Ph.DVice President of Antibody Technologies
Frank Lee Ph.D Founder, Board Member & Chief Executive Officer
Elizabeth Moyer Ph.D Head, Nonclinical Development
Michael Gramer Ph.D Head of Process Development and Manufacturing
John Abrams Ph.D Vice President of Antibody Technologies
Request full access to PitchBook